CA
VRTX icon

Clearstead Advisors’s Vertex Pharmaceuticals VRTX Stock Holding History

Clearstead Advisors’s Portfolio VRTX Stock Details VRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.24M Buy
4,510
+1,083
+32% +$480K 0.02% 363
2026
Q1 		$1.53M Sell
3,427
-100
-3% -$46.6K 0.01% 420
2025
Q4 		$1.6M Hold
3,527
– – 0.02% 375
2025
Q3 		$1.38M Buy
3,527
+7
+0.2% +$2.92K 0.02% 383
2025
Q2 		$1.57M Sell
3,520
-34
-1% -$15.7K 0.02% 360
2025
Q1 		$1.72M Buy
3,554
+117
+3% +$54.5K 0.03% 327
2024
Q4 		$1.38M Sell
3,437
-119
-3% -$55.2K 0.02% 355
2024
Q3 		$1.65M Buy
3,556
+1
+0% +$480 0.03% 331
2024
Q2 		$1.67M Buy
3,555
+2,928
+467% +$1.27M 0.03% 302
2024
Q1 		$270K Buy
627
+146
+30% +$61.7K 0.01% 416
2023
Q4 		$196K Sell
481
-91
-16% -$33.6K 0.01% 458
2023
Q3 		$199K Buy
572
+307
+116% +$107K 0.01% 571
2023
Q2 		$93.3K Sell
265
-6
-2% -$2.02K 0.01% 595
2023
Q1 		$85.4K Sell
271
-218
-45% -$65.4K 0.01% 537
2022
Q4 		$141K Hold
489
– – 0.01% 429
2022
Q3 		$142K Buy
489
+485
+12,125% +$140K 0.01% 413
2022
Q2 		$1K Hold
4
– – ﹤0.01% 1237
2022
Q1 		$1K Buy
+4
New +$949 ﹤0.01% 1334
2021
Q2 		– Sell
-158
Closed -$34K – 1307
2021
Q1 		$34K Buy
+158
New +$34.7K ﹤0.01% 591
2020
Q2 		– Sell
-20
Closed -$5K – 840
2020
Q1 		$5K Buy
+20
New +$4.59K ﹤0.01% 657

Other funds holding VRTX

Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Clearstead Advisors's VRTX Position: Q2 2026 in Review

Clearstead Advisors increased its Vertex Pharmaceuticals (VRTX) stake by 32% in Q2 2026, buying an estimated $480K and bringing the position to 4,510 shares worth $2.24M. The position accounts for 0.02% of the portfolio, ranked #363.

Clearstead Advisors first reported a position in VRTX in Q1 2020 and has held it in 20 quarters since. 1,747 funds tracked by Wall St. Rank hold VRTX as of Q2 2026.

  • Clearstead Advisors held 4,510 shares of Vertex Pharmaceuticals worth $2.24M as of Q2 2026.
  • Clearstead Advisors bought 1,083 Vertex Pharmaceuticals shares in Q2 2026, an estimated $480K.
  • Vertex Pharmaceuticals made up 0.02% of Clearstead Advisors's portfolio in Q2 2026, its #363 holding.
  • Clearstead Advisors first reported a position in Vertex Pharmaceuticals in Q1 2020 and has held it in 20 quarters since.
  • 1,747 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q2 2026.

Based on Clearstead Advisors's 13F filing for Q2 2026, filed 6 Aug 2026.